"Advanced Dermatology and Cosmetic Surgery is the largest team of dermatology experts in the US. We offer comprehensive care for skin, hair, and nail conditions, annual Total-Body Skin Cancer Exams, Mohs surgery, advanced aesthetic services, an online shop of dermatologist-developed products, and clinical research trials to combine the best of the art of medicine with the latest advances in skin care therapy. Our goal is to help each patient achieve healthy, radiant skin with the most effective combination of anti-aging treatments and skin care products. We are committed to providing unparalleled patient care in Ft. Washington while leveraging the vast knowledge and resources of our extensive national team."

During the past decade, Philadelphia Institute of Dermatology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Philadelphia Institute of Dermatology" #1 sponsor was "LEO Pharma" with 4 trials, followed by "Galderma R&D" with 3 trials sponsored, "Veloce BioPharma LLC" with 2 trials sponsored, "Aclaris Therapeutics, Inc." with 1 trials sponsored and "Actavis Mid-Atlantic LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Philadelphia Institute of Dermatology" are "Actinic Keratosis" (2 trials), "Psoriasis Vulgaris" (2 trials), "Rosacea" (2 trials), "Actinic Keratoses" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Philadelphia Institute of Dermatology" in a lesser frequency.

Most popular intervention types in "Philadelphia Institute of Dermatology" are "Drug" (12 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vehicle" (3 trials), "LEO 90100" (2 trials), "2014-ALC-919-US" (1 trials), "A-101" (1 trials) and "Azelaic acid 15% Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Philadelphia Institute of Dermatology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Philadelphia Institute of Dermatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Philadelphia Institute of Dermatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Philadelphia Institute of Dermatology, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".